|
FY2026
12 months to Jan 31, 2026
|
FY2025
12 months to Jan 31, 2025
|
FY2024
12 months to Jan 31, 2024
|
FY2023
12 months to Jan 31, 2023
|
FY2022
12 months to Jan 31, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of deferred contract acquisition costs | |||||
| Net accretion on marketable securities | |||||
| Stock-based compensation expense | |||||
| Charitable donation of Class A common stock | |||||
| Non-cash operating lease expense | |||||
| Abandonment and impairment charges | |||||
| (Benefit from) provision for deferred income taxes | |||||
| Credit loss expense (benefit) | |||||
| Other non-cash charges (credits), net | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Contract assets | |||||
| Deferred contract acquisition costs | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Accrued compensation and employee benefits | |||||
| Operating lease liabilities, net | |||||
| Deferred revenue | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of marketable securities | |||||
| Sales of marketable securities | |||||
| Maturities of marketable securities | |||||
| Purchases of property and equipment | |||||
| Payments related to business acquisitions, net of cash acquired | |||||
| Capitalized software development costs | |||||
| Purchases of investments | |||||
| Other investing, net | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Repurchases of Class A common stock | |||||
| Proceeds from exercise of stock options | |||||
| Payments of tax withholdings on net settlement of equity awards | |||||
| Net receipts (payments) of tax withholdings on sell-to-cover equity award transactions | |||||
| Proceeds from employee stock purchase plan contributions | |||||
| Repurchase of unvested early exercised stock options | |||||
| Proceeds from initial public offering, net of underwriting discounts and commissions | |||||
| Payments of initial public offering costs | |||||
| Proceeds from issuance of convertible preferred stock | |||||
| Issuance costs related to convertible preferred stock | |||||
| Payments of deferred or contingent consideration related to business acquisitions | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes | |||||
| Net decrease in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Cash, cash equivalents, and restricted cash at end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes, net | |||||
| Supplemental disclosures of non-cash investing and financing activities: | |||||
| Stock-based compensation capitalized for software development | |||||
| Value of shares issued in payment of business acquisitions | |||||
| Deferred and contingent consideration recognized in connection with business acquisition | |||||
| Reduction in accrued expenses and other liabilities for vesting of early exercised stock options | |||||
| Tax withholdings on net settlement of restricted stock units, accrued but not yet paid | |||||
| Property and equipment purchases included in accounts payable | |||||
| Payable for repurchase of Class A common stock | |||||
Loading...